PAR 15 A COMPARISON OF COST OF INFLIXIMAB AND ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN ITALY- RESULTS OF THE IERI STUDY GROUP
Abstract
Authors
S De Portu G Ferraccioli P Sarzi-Purrini U Fiocco C Montecucco A Valesini B Canesi G Leardini M Mecchia LG Mantovani